Wei Li

Wei Li, PhD, is an Associate Professor in the Department of Pharmacology and Physiology. His research program spans molecular pharmacology, cancer biology, proteomics, and infectious disease mechanisms, with a strong focus on understanding disease pathogenesis and developing therapeutic strategies.

Dr. Li's research interests include:

• Cancer therapeutics development (particularly breast cancer and leukemia)
• Molecular mechanisms of receptor signaling in respiratory and cardiovascular systems
• Proteomic approaches to biomarker discovery
• Host-pathogen interactions in bacterial and viral infections
• Metabolic regulation in disease states

Analysis of Dr. Li's recent publications (2022-2025) reveals consistent focus on:

• Mechanistic studies of kinase signaling pathways in cancer and inflammation
• Proteomic investigations of disease mechanisms using advanced mass spectrometry
• Development of novel compounds targeting cancer and respiratory diseases
• Translational research connecting molecular mechanisms to clinical applications

Dr. Li maintains active research collaborations as evidenced by diverse publication topics, though specific laboratory or team details are not provided in the source material. No information is available regarding student mentorship, grant funding, or scientific awards in the extracted text.